The Great Debate II: Survival & Durability Considerations with AVR

The Great Debate II: Survival & Durability Considerations with AVR

The Great Debate II: Survival & Durability Considerations with AVR

Aortic valve replacement is going through a paradigm shift. Innovation in the type of intervention and valve options has opened up new opportunities for patients and clinicians. When it comes to valve choice for long-term outcomes, durability and antithrombotic therapy becomes the crux of the discussion, as patients question the impact to their lifestyle after undergoing an aortic valve replacement. This webinar brings renowned Cardiologists and Cardiac Surgeons at the same table to discuss and debate “How Well” a patient will live their long lives with aortic valve options of today and possibilities for future.

Moderator:

Dr. James Hermiller
Interventional Cardiology, Cardiology
St. Vincent Center, Indianapolis

Presentation Topics:

Bioprostheses:
Long-Term Outcomes
Dr. S. Chris Malaisrie
Professor of Surgery (Cardiac Surgery),
Northwestern University, Chicago

Mechanical SAVR: 
Data Vs. Perception
Dr. Marc W. Gerdisch
Chief of Cardiothoracic Surgery
Franciscan Health Heart Center, Indianapolis

Ross Procedure:
Time to Revisit the Guidelines
Dr. Ismail El-Hamamsy
Director, Aortic Surgery
Mount Sinai, New York

 

 

 

The views expressed during this presentation are the speaker’s own and do not necessarily reflect those of CryoLife, the speaker’s employer, organization, committee or other group or individual.  Unattributed data, device selection, and procedural guidance is a matter of physician preference are presented on the basis of the individual speaker’s observations and experiences and should be treated accordingly. Federal law restricts the devices discussed herein to sale by or on the order of a physician. Refer to the Instructions for Use and other product insert documentation that accompanies each of these devices for indications, contraindications, warnings, precautions, possible complications, and instructions for use.  

On-X® Prosthetic Heart Valves IFU’s

Products not available in all markets.  The content of this presentation, including any copyrightable content included herein, is used with permission from the speaker.

On-X Life Technologies, Inc. is a wholly owned subsidiary of CryoLife, Inc. The On-X® Prosthetic Heart Valves are manufactured by On-X Life Technologies, Inc. The snowflake design, CryoLife, Life Restoring Technologies, and On-X are registered trademarks owned by CryoLife, Inc. or its subsidiaries. All other registered trademarks are owned by their respective owners. © 2021 CryoLife, Inc. All rights reserved.


Created by

CryoLife